Beta2-Agonists and Asthma in Children
Author(s) -
Guy Lapierre
Publication year - 1995
Publication title -
canadian respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.675
H-Index - 53
eISSN - 1916-7245
pISSN - 1198-2241
DOI - 10.1155/1995/697362
Subject(s) - medicine , tachyphylaxis , asthma , b2 receptor , dose , beta (programming language) , pediatrics , bronchodilator agents , intensive care medicine , bronchodilator , bradykinin , receptor , computer science , programming language
Due to the growing prevalence and morbidity of asthma in children in the past few years, Canadian physicians have addressed several issues concerning the correct use of beta2-agonists for the treatment of asthma. These issues include the optimum delivery systems for beta2-agonists, their appropriate dosages in children, infants and toddlers, andwhether tachyphylaxis occurs with their chronic use
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom